Menu
← Oncology Approval Tracker
FDA DECISION ·
Opdivo + chemotherapy
nivolumab with fluoropyrimidine- and platinum-containing chemotherapy · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Advanced or metastatic gastric, gastroesophageal junction or esophageal adenocarcinoma treated with nivolumab plus a fluoropyrimidine and platinum regimen.
LAMPGEN ANALYSIS
Why it matters
The action adds PD-1 blockade to chemotherapy in a group of advanced upper gastrointestinal adenocarcinomas.
What research teams should watch
Verify histology and anatomic site, and retain the date-specific FDA indication when comparing biomarker-defined cohorts.
PRIMARY RECORDS